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Abstract: Background: Disease prioritization aims to enhance resource use efficiency concerning
human and animal health systems’ preparedness and response to the most important problems
for the optimization of beneficial outcomes. In sub-Sahara Africa (SSA), several prioritizations of
zoonoses and transboundary animal diseases (TADs) have been implemented at different scales to
characterize potential disease impacts. Method and principal findings: In this systematic review, we
analyze the methodologies used, outcomes, and their relevance by discussing criteria required to align
decision-makers’ perceptions of impacts to those of other stakeholders for different prioritization in
SSA. In general, the sectorial representativeness of stakeholders for processes implemented with the
support of international partners showed slight differences with the absence of local stakeholders.
Whatever the tool prioritized, zoonoses were similar in general because of the structured nature of
those tools in assessing decision-makers’ preferences through value trade-offs between criteria while
ensuring transparency and reproducibility. However, by involving field practitioners and farmers,
there were different outcomes with processes concerning only decision makers and experts who
were more sensitive to infectious TADs, while the former raised parasitic disease constraints. In this
context, multicriteria decision analysis-based zoonoses and TADs prioritizations involving a balanced
participation of stakeholders might contribute to bridging these divergences, whatever the scale.
Conclusion and significance: Prioritization processes were important steps toward building and
harmonizing technical laboratory and surveillance networks to coordinate projects to address priority
zoonoses and TADs at the country and/or sub-regional level. Those processes should be enhanced.
Keywords: zoonoses; transboundary animal diseases; prioritization; Africa; critical systematic review
1. Introduction
The use of prioritization exercises for the ranking of diseases has spread from America
(Canada) in 1987 [1] to other countries and continents [2]. Prioritization is the hierarchical
organization of the list of pathologies by evaluating their socioeconomic and zoonotic
impacts [3]. The process aims to provide decision makers with a tool to help them select
the infectious risks and threats that deserve governments’ prioritization and for which
appropriate preventive monitoring or control measures are needed [3]. This allows a
more efficient allocation of resources (human and financial) for preparation, detection, and
response measures with respect to disease prevention and control [2]. Once the goals are
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set, it is imperative to verify the adequacy of the current surveillance system and update it
if necessary [4]. Indeed, in a context where these resources are limited, prioritization can
help to concentrate resources in the right place according to one or more global objectives.
The prioritization of animal diseases is applicable at the farm level with the participation of
livestock farmers and animal health care professionals, in particular during health assess-
ment. This includes identifying the dominant pathologies on farm, defining and adjusting
priority mitigation measures as well as preventive measures to be implemented [5]. In
addition to activities carried out at the local level, the research, prevention, and imple-
mentation of measures to combat animal diseases are mainly coordinated at national and
regional levels [6]. Indeed, industrialization and economic development have encouraged
the flow of so-called transboundary diseases across borders. Thus, the spread of infectious
animal diseases is driven by many factors, such as the movement of humans and animals
across borders, contact between wild and domestic animals, and between humans and
animals [5]. Likewise, the effect on production and trade can affect not only the local
economy but also the economy at the level of a group of countries and even globally. The
prioritization of animal diseases and zoonoses is a complex process that must respond to
health, economic, and societal priorities that are often difficult to prioritize but also must
be based on a consensus between the different interested parties (breeders, veterinarians,
citizens, political authorities) [7]. The prioritization of animal diseases appeared to be an
essential step in optimizing the planning and allocation of limited resources that is rational,
explicit and transparent.
International bodies such as World Health Organization (WHO), World Organization
for Animal health (OIE), and Food and Agricultural Organization (FAO) attach importance
to the prioritization of diseases. They implemented international disease prevention and
control strategies and proposed disease prioritization as a way to improve various diseases
prevention and control efforts. In this regard, in 2006, the WHO published guidelines
on communicable disease surveillance priorities that emphasize a prioritization role in
improving disease surveillance systems at national and regional levels [8]; then, they
developed a methodology to prioritize emerging infectious diseases in need of research
and development [9]. Likewise, in 2014, the OIE published criteria and factors for the
rational prioritization of animal diseases with public sanitary concerns for policy. Later on,
many countries have initiated a prioritization process and are integrating this process as an
aid in the management of animal and public health problems [7,8]. The methods used for
prioritization range from qualitative to quantitative through semi-quantitative methods
depending on the criteria measurement used and the type of data required [10]. Each
method has its own strengths and weaknesses. Therefore, their choice and use in a specific
context are subject to prior relevance and feasibility analyses in relation to prioritization
purposes [2].
The recent growing interest and advocacy by non-profit organizations, governments,
industries, and academia toward the “One Health Approach” in mitigating overlapping
health problems between human, animal, and environment sectors have triggered the
prioritization of zoonotic diseases in several low–middle income countries worldwide
in order to coordinate preparedness and response across sectors more effectively [11]. A
recent study has analyzed themes from one health zoonotic diseases workshops using the
One Health Zoonotic Disease Prioritization (OHZDP) tool developed by CDC [10] in seven
countries worldwide from 2014 to 2016, during the pilot phase of the tool development
and testing [11]. Yet during the same period and later on, several such exercises have
been carried out in other countries using the same tool or other tools such as the OIE
Phylum tool [3]. Since the categorization and prioritization of diseases is not a rigid
and permanent assessment requiring progressive and constant updating and iterations
with respect to changes in (e.g., because it is non-exhaustive) scientific knowledge, local
situation, and economic context [3], we analyze themes from animal and zoonotic diseases
prioritization processes in African countries in order to draw country and regional-specific
implications for the operationalization of outcomes of these processes as far as animal
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and zoonotic disease surveillance and control is concerned. Thus, therefore, it appears to
be an imperative in the implementation and operationalization of zoonoses and animal
health strategies. The aim of this review paper is to perform a critical systematic review of
prioritization processes of zoonoses and transboundary animal diseases in Africa.
2. Results
2.1. Overview of Zoonosis and Transboundary Animal Disease Prioritization in Africa
The database search yielded nine relevant animal prioritization reports and 16 pub-
lished papers relevant to our study. All studies were carried out and published between
2015 and 2021 (Table 1). Three animal and zoonotic disease prioritization tools were used:
the OHZDP tool of the CDC [10], the OIE Phylum tool [3], and participatory epidemiology
(including surveys and literature review), which is a method that promotes the active
involvement and cooperation of researchers and researched populations such as livestock
farmers. A total of 16 SSA countries were concerned by the present study:
• Four countries (Ethiopia, Kenya, Tanzania, and Uganda) implemented both animal
and zoonotic disease prioritization processes at the national level using the Phylum
and the OHZDP tool;
• Six countries (Burkina Faso, Cameroon, Cote d’Ivoire, Democratic Republic of Congo,
Mali, Mozambique) were concerned only by zoonotic disease prioritization at the
national level using the OHZDP tool;
• Six countries (Burundi, Djibouti, Eritrea, Rwanda, South-Sudan, Sudan) used the
Phylum tool to prioritize TADs and zoonoses at the national level.
A local prioritization of animal diseases (participatory epidemiology) concerning
one of the sixteen countries above (Ethiopia) and regional prioritizations of zoonoses and
animal diseases in West and East Africa were retrieved as well.
For regional and national prioritization, workshops were specifically conducted, and
all processes aimed at identifying and prioritizing either only zoonotic diseases or both
zoonoses and animal diseases. Subject expert matters (or trained facilitators) contributed to
the processes whatever the tool used following standard procedures previously described.
2.2. Prioritization Processes by Stakeholders
During the OHZDP process at the national level, participating members were grouped
by their agencies and voted on the ranking or weight applied to each criterion before
conducting a final ranking of diseases. Participants belonged to different national sectorial
or administrations including public health (all countries), animal health (all countries),
wildlife and environmental health (all countries), research institutions (all countries), local
universities (half the countries), international partners, one health coordinating institutions
(one-third of the countries), and military and security services (one-fifth of the countries).
The private sector was involved only in two out of the ten concerned countries, and the
participants were from central or national administration for all countries (Figure 1). The
participating stakeholders for the regional prioritization came from the 15 countries and
their institutions were similar to the one from the national OHZDP processes.
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Table 1. Location, scales, purposes, and tools used for animal and zoonotic disease prioritization in SSA countries.
Region–Country–Locality Year Scale Purpose of Prioritization Methods Reference
Burkina Faso, Cameroon, Cote d’Ivoire,
Democratic Republic of Congo, Ethiopia *,
Kenya *, Mali, Mozambique, Tanzania *,
Uganda *
2015–2018 National
To identify zoonotic diseases of greatest
national concern for the concerned
countries using equal input from
representatives of human health, animal
resources, and the environment
Semi quantitative, CDC OHZDP tool [12–23]
Burundi, Djibouti, Eritrea, Ethiopia *, Kenya *,
Rwanda, South-Sudan, Sudan, Tanzania *,
Uganda *
2015–2016 National
To identify, prioritize, and categorize the
key transboundary animal diseases and
zoonoses for public policy and animal
health programs at the national level
Semi quantitative, OIE Phylum tool [24–33]
ECOWAS (Benin, Burkina Faso Cape Verde,
Côte d’Ivoire, Gambia, Ghana, Guinea,
Guinea Bissau, Liberia, Mali, Niger, Nigeria,
Senegal, Sierra Leone, Togo
2019 Regional
To use a multisectoral, One Health
approach to identify zoonotic diseases of
greatest regional concern for ECOWAS
(13 countries)
Semi quantitative, CDC OHZDP tool [34]
Ethiopia * (districts of Lalibela, Sekota,
and Ziquala) 2016–2018 Local
To identify and prioritize primary cattle
disease with the aid of participatory
epidemiology tools (i.e., focus group
discussions and questionnaires)
Participatory epidemiology tool [35]
West Africa: Senegal, Mali, Ghana, Burkina
Faso, Cote D’Ivoire, Chad, Togo, Benin,
Nigeria, Sierra Leone.
East Africa: Tanzania *, Kenya *, Uganda *,
Ethiopia *, South Sudan,
Malawi, Mozambique, Zambia
2019 Regional
To prioritize animal health needs in East
and West Africa and South Asia to identify







Legend: * Countries that implemented animal and zoonotic disease prioritization using the CDC OHZDPT (One Health Zoonotic Disease Prioritization Process) and the OIE Phylum tool; ECOWAS: Economic
Community of West African States.
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The prioritization of TADs and zoonoses using the Phylum tool was carried out by
senior experts from the national veterinary departments (all countries), public health de-
partments (three-fifths of the countries), and international partners (all countries). Wildlife,
administrative authorities, and One Health coordinating institutions were each involved in
only one of the ten countries. In all countries, participants were mainly from the public
sector and from central or national administration for all countries (Figure 2).
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2.3. Zoonoses and Transboundary Animal Diseases Prioritization Criteria Chosen by Countries
For the OHZDP process, irrespective to the assigned weight, the most frequent disease
ranking criteria used were (Table 2):
• Severity of disease in humans (all countries),
• Availability of interventions (i.e., vaccines and/or medical treatment) (all countries),
• Economic, environmental, and/or social impact (9/10 countries),
• Presence of disease in country and/or region (8/10 countries),
• Epidemic/pandemic potential (and/or sustained transmission in humans) (7/10 countries).
Table 2. Disease ranking criteria chosen by country during One Health Zoonotic Disease Prioritization workshops in ten
SSA countries a.
Disease Ranking Criteria No. Countries Average Assigned Weight (Range)
Economic, environmental, and/or social impact 9 0.170 (0.105–0.210)
Economic impact only 0
Economic and/or social impact 5
Economic, environmental, and/or social impact 4
Availability of interventions (i.e., vaccines and/or medical treatment) 10 0.174 (0.130–0.206)
Epidemic/pandemic potential (and/or sustained transmission in humans) 7 0.201 (0.170–0.220)
Human-to-human transmission potential 7
History of previous outbreaks 0
Severity of disease in humans 10 0.231 (0.180–0.350)
Case-fatality rate 8
Morbidity and/or mortality rate 2
Presence of disease in country and/or region 8 0.232 (0.170–0.330)
Human and/or animal cases of illness reported in country
and/or region 6
Human or animal disease prevalence and distribution in country 2
Laboratory capacity/diagnostic testing capacity 2 0.151 (0.143–0.160)
Existing multisectoral collaboration 1 0.170 (NA)
Bioterrorism potential 3 0.102 (0.040–0.187)
Mode of transmission 1 0.200 (NA)
Legend: a Countries: Burkina Faso, Cameroon, Cote d’ Ivoire, Democratic Republic of Congo, Ethiopia, Kenya, Mali, Mozambique,
Tanzania, Uganda; NA: not available.
With the Phylum tool, the importance of the listed diseases was assessed based on
the scoring of selected specific criteria including local economic impact, local public health
impact, local societal impact, local environmental impact, and the local feasibility, economic,
societal, and environmental impact of control measures. The assessments considered
both present and absent diseases (Phylum). For each listed disease, the tool uses expert
opinion bases on data from public health and veterinary services, statistics from health
information systems (e.g., World Animal Health Information System (WAHIS) from OIE,
FAO (Empres-I), AU/IBAR (Aris) OMS) for the prioritization of TADs and zoonosis. The
analysis of a disease is made in two sequential steps: first, a global characterization of
the disease, aiming at assessing the different above-mentioned impacts within the region,
independent of any particular local context [3]. Depending on the selected criteria, the
characteristics of the studied diseases, and local contingencies, the scores may not be
homogenous between the different modules applied, therefore requiring standardization
of the results. Then, results are subjected to discussions (subject matter expert opinion) by
stakeholders in the country who provide their inputs and a final list of prioritization [3].
Five countries (Burundi, Djibouti, Eritrea, South Sudan, and Sudan) provided detailed lists
of justifications used for scoring diseases in each of the seven criteria used for classification
by the Phylum tool (Table 3). Based on the local economic impact, the main justifications
used were trade and export bans (all the five countries), high morbidity, high mortality,
and hindering industry (four countries out of the five for each justification). For public
health impact, the zoonotic status of the disease (all five countries), high cost of control and
prevention for public health (four out of five countries), export and trade bans (three out of
five countries) were the main justifications. Considering the social impact of diseases, the
zoonotic status of the diseases (all the five countries), mortality in animals, mortality/case
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fatality in humans, negative impact on pastoralists such as poverty (four out of five
countries each) were mainly used for disease scoring. The local environmental impact
justifications used for disease scoring were mainly biological and chemical contamination of
the environment (all five countries), and the disposal of infected and dead animals (four out
of five countries). For the feasibility of control measures, the extend of public importance
and implications, mortality rate, vaccination constraints (three out of five countries each)
were considered for disease scoring. Trade bans (four out of five countries), the endemic
status of the disease, highly contagious diseases, the high cost of control and prevention
for public health, human economic impacts, zoonotic status of diseases (three out of five
countries each) were used as justification for the scoring of diseases based on the local
economic impact of control measures. Control measures’ constraints (all five countries) and
wildlife susceptibility (three out of five countries) were the main justifications considered
for scoring the diseases according to the local societal and environmental impact of control
measure criterion.
Table 3. Justifications used in the literature for the Phylum prioritization of transboundary animal diseases and zoonoses in
five SSA’s countries a.
Classification Criteria
Economic Impact Human Health Impact Societal Impact Environmental Impact
Justification % Justification % Justification % Justification %
Export and




High cost of control
and prevention for
public health
80 Mortality in animals 80 Disposal of animals 80
High morbidity 80 Export andtrade bans 60
Mortality/case
fatality in humans 80
Cleaning and
disinfecting costs 60




80 Risk for wildlife 60
High cost of animal
disease control and
prevention
60 Number of reportedcases 40
Impact on
consumption habit 60
High cost of control
and prevention for
public health
60 Mode oftransmission 40 Morbidity in animals 60
Cost if introduced 40 Mortality/casefatality 40 Production lost 60
Highly contagious 40 Bioterrorismpotential 20 Social stress 60
Production lost 40 Effect on livelihood 20
Zoonotic disease 40 Endemic zoonoses 20




Endemic disease 20 Food borne 20




Food borne 20 Highly contagious 20 Number ofreported cases 40
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Table 3. Cont.
Classification Criteria
Economic Impact Human Health Impact Societal Impact Environmental Impact














60 Trade bans 80 Control measures’ constraints 100
High mortality 60 Endemic 60 Wildlife susceptibility 60
Vaccine constraints 60 Highly contagious 60 Zoonotic disease 40
Culling constraint 20







20 Human economicimpacts 60 Mortality 40
Testing constraints 20 Zoonotic disease 60 Consumption habit 20
Local and




production costs 20 Environmental contamination 20
Vector control
feasibility 20 Control constraints
Zoonotic disease 20
Legend: a Burundi, Djibouti, Eritrea, South Sudan, Sudan.
2.4. Zoonoses and Transboundary Animal Diseases Ranking
As a result of the OHZDP tool’s ranking process, the ten countries listed on average
38.5 zoonotic diseases (range: 11–48) of which 5.7 (range: 5–7) and 0.6 (range 0–1) en-
demic and exotic zoonoses were prioritized, respectively (Table 4). Eighteen zoonoses or
syndromes were ranked as priority zoonotic diseases (Table 5). Of those, rabies (n = 10),
anthrax (n = 7), brucellosis (n = 7), zoonotic influenza virus (n = 7), and hemorrhagic
fever (Ebola/Marburg) (n = 6) were the top five most prioritized zoonoses amongst the
studied countries. Of that ranking zoonotic influenza virus (n = 2), hemorrhagic fever
(Ebola/Marburg) (n = 2), trypanosomiasis (n = 1), and dengue (n = 1) were the ones ranked
as exotic zoonotic diseases. Within the ECOWAS region, 30 zoonotic diseases were listed,
and seven (anthrax, rabies, viral hemorrhagic fevers (Rift valley fever, Ebola, Crimean
Congo hemorrhagic fever, Marburg), zoonotic influenzas, zoonotic tuberculosis, trypanoso-
miasis, and yellow fever) were selected as priority zoonoses. Eleven, five, and two zoonoses
prioritized by the ten countries were caused by viruses, bacteria, and parasites, respectively.
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Table 4. Number of animal diseases and zoonoses listed for prioritization in SSA countries.






























Burkina Faso a 41 4 1 5
Burundi b 23 10 6 16
Cameroon a 41 4 1 5




11 6 0 6
Djibouti b 15 6 0 6
Eritrea b 16 7 4 11
Ethiopia c 43 5 0 5 16 7 3 10
Kenya c 36 5 0 5 15 13 2 15
Mali a 38 5 0 5
Mozambique a 48 6 1 7
Rwanda b 16 10 6 16
South-Sudan b 15 12 3 15
Sudan b 11 6 6 12
Tanzania c 39 5 1 6 16 7 2 9
Uganda c 48 6 1 7 16 10 3 13
Average (S.E. **) 38.5 (3.30) 5.1 (0.23) 0.6 (0.16) 5.7 (0.26) 15.9 (0.92) 8.8 (0.80) 3.5 (0.64) 12.3 (1.05)
Legend: * OHZDP: One Health Zoonotic Disease Prioritization; S.E. **: standard error of the mean; a: countries that prioritized zoonotic
diseases using the OHZDP tool; b: countries that prioritized transboundary animal diseases and zoonoses using the OIE Phylum tool;
c: countries that carried out both prioritization processes; No: Number.
Table 5. Top zoonoses and transboundary animal diseases (TAD) prioritized by the OHZDP and Phylum Tools in SSA.
Type Disease or Health Condition CausativeAgent No of Countries
OHZDP Tool a Phylum Tool b
Endemic Exotic Endemic Exotic
Zoonosis
Rabies Virus 10 7 1
Anthrax Bacteria 7 1
Brucellosis Bacteria 7 8
Zoonotic influenza Virus 5 2 1 9
Hemorrhagic fever
(Ebola/Marbug) Virus 4 2 2
Rift Valley fever Virus 4 3 5
Trypanosomiasis Parasite 3 1 1
Zoonotic tuberculosis (M. bovis) Bacteria 3 6 1
Lassa Virus 2
Salmonellosis Bacteria 2






Monkey pox Virus 1
Plague Virus 1
MERS-CoV ** Virus 1
Swine erysipelas 1
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Table 5. Cont.
Type Disease or Health Condition CausativeAgent No of Countries
OHZDP Tool a Phylum Tool b
Endemic Exotic Endemic Exotic
TAD
Foot and mouth disease Virus 10 6
Peste des petits ruminants Virus 9 1
Contagious bovine
pleuropneumonia Bacteria 8 2
New Castle disease Virus 7
Contagious caprine
pleuropneumonia Bacteria 5
African swine fever Virus 4 1
Lumpy skin disease Virus 4
Sheep and goat pox Virus 3 1
East coast fever Parasite 2
Porcine cysticercosis Parasite 1
Classical swine fever Virus 1
PRRS *** Virus 1
Camel pox Virus 1
Legend: * e.g.: yellow fever and West Nile disease; ** MERS-CoV: Middle East respiratory syndrome; *** PRRS: porcine reproductive and
respiratory syndrome; a: countries that used the OHZDP tool (Burkina Faso, Cameroon, Cote D’ Ivoire, Democratic Republic of Congo,
Ethiopia, Kenya, Mali, Mozambique, Tanzania, Uganda); b: countries that used the Phylum tool (Burundi, Djibouti, Eritrea, Ethiopia,
Kenya, Rwanda, South-Sudan, Sudan, Tanzania, Uganda); No: number.
Amongst the ten countries that implemented the Phylum prioritization process, 15.90
(range: 11–23) of which 8.80 (range: 6–12) and 3.50 (range 2–6) were endemic and exotic
TADs and zoonoses were prioritized respectively in each country (Table 4). Nine endemic
TADs and nine zoonosis or syndromes were prioritized (Table 5). Of those, the top five most
ranked endemic TADs were foot and mouth disease (n = 10), peste des petits ruminants
(n = 9), contagious bovine pleuropneumonia (n = 8), New Castle disease (n = 7), and
contagious caprine pleuropneumonia (n = 5). Brucellosis (n = 8), rabies (n = 7), and
tuberculosis (Mycobacterium bovis) (n = 6) were zoonoses ranked by the most countries. In
addition, exotic priority diseases were ten TADs and four zoonoses where specific serotypes
of foot and mouth disease (n = 9) was the main exotic TADs ranked (Table 5). Highly
pathogenic avian influenza (n = 10) and Rift valley fever (n = 5) were the most prioritized
zoonoses when being exotic to the country. Endemic TADs prioritized were caused by
viruses (n = 6), bacteria (n = 2), and parasites (n = 1). Three, four, and two endemic zoonosis
were caused by viruses, bacteria, and parasites, respectively. Eight and two exotic TADs
prioritized were caused by viruses and bacteria, respectively. All exotic zoonoses (n = 4)
prioritized were caused by viruses.
3. Discussion
The need of achieving the optimal benefit in tackling animal and human health chal-
lenges or constraints has prompted the prioritization of diseases as a strategic process
ensuring efficient use of limited resources to target the most important problems. The
process of prioritizing animal diseases and zoonoses has been implemented previously
in different locations, with different magnitudes and purposes in South and North Amer-
ica [37,38], Europe [39–42], Asia, and Africa [2] (Table 1). Those studies have ranked various
types of diseases such as zoonotic and foodborne diseases, based on several measured
and weighed criteria that describe or characterize potential disease impacts [2]. This study
has reviewed recent prioritization processes carried out in SSA with various tools used at
different scales in the context of “One Health”. A previous study has included five SSA
countries in such an analytical review of prioritization processes together with two other
countries from South Asia [11] using the OHZDP tool. However, several animal diseases
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prioritization processes have been implemented during the same timeframe or later on
using the same tool or other diseases prioritization tools. In this study, the prioritization
of TADs and zoonoses has been considered at the country level (n = 16) using previously
developed prioritization tools. In addition, regional (West and East Africa countries) and
local (District) level prioritization processes were also taken into consideration. To the best
of our knowledge, this study is one of the few of its kind to gather knowledge generated
through several prioritization processes using different tools in SSA whereas previous
synthetic works focused on analyzing data generated through the processes using the same
tool [11].
For the prioritization of animal diseases and zoonoses, it has previously been argued
that using an interdisciplinary team of participants (facilitating and voting) who stay neu-
tral, unbiased, and do not focus on their specific sector, affiliation, or area of expertise
enables voting members’ voices to be heard and recognized [2,11]. In this study, we found
that the OHZDP tool thrives to meet the interdisciplinary and multisectorial compliance
throughout the process more than the Phylum tool does. The other processes gave fewer
details as far as experts involved in the process of prioritization were concerned. Yet it
must be pointed out that the animal and human health private sectors and local or field
professionals were less involved during both processes, making them elitist and top–down
decision-making approaches whereby governmental sectors and top ranked professionals
at the central or national level identify and classify priority diseases and impose them on
private practitioners and field or peripheral professionals. This can implicitly have negative
implications at the operationalization phase of the use of the priority disease lists and the
implementation of mitigating actions (poor community engagement). To cope with the chal-
lenge of dealing with several pathogens posing specific threats to animal and public health,
all prioritization processes required an extensive literature review. The latter allowed the
identification of diseases relevant to classification and sound evidence-based prevention
and control measures as well as efficient resource allocation [2,39]. Indeed, in this study,
there was a wide variation of disease list lengths (number of listed diseases) between
countries whatever the prioritization method used. Prioritization processes were held
during a workshop (or focus group discussion and surveys) following a preparation period
lasting several months and deeply relying on local partners’ engagement and implication
of technical and financial partners [3,10,35,36]. Criteria identification and/or weighing or
disease classification based on previously identified criteria were performed by the selected
participants. Despite the differences existing between the different prioritization processes,
economic, human health, societal, and environmental impact are the most used categories
(with specific weighing and scoring justifications), as diseases are responsible for a variety
of overlapping impacts than span over these different categories [43]. In fact, there are sev-
eral drivers of disease impacts, including for instance climatic, biophysical, anthropogenic,
and epidemiological factors resulting in a wide variation of disease importance according
to species, scale (local, national, regional, global), and the perception of stakeholders [44].
Thus, defining disease importance is not a straightforward and trivial process as shown
by past and recent development of disease prioritization processes [2,42]. For most tools,
no matter the disease types of interest (zoonoses or animal diseases), the selected criteria
mainly targeted diseases known to be present in the country except for the Phylum tool,
where distinction is made between endemic and exotic diseases during the prioritization
process [3].
Whatever the tool used at the country level (CDC OHZDP or OIE Phylum), zoonotic
diseases that were most frequently prioritized were rabies, brucellosis, hemorrhagic fevers
(Marburg/Ebola), anthrax, Rift Valley fever, and zoonotic tuberculosis. For public health,
this consensus on prioritized zoonoses also shows how these endemic diseases are impor-
tant at the country and continental level. Rabies is an acute and progressive viral encephali-
tis causing approximately 59,000 human deaths annually in Africa and Asia [45,46], and
it is responsible for more than 1.74 disability-adjusted life years (DALYs) lost each year,
which makes it an important yet neglected disease in Africa and Asia [47]. Brucellosis
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is a group of zoonoses caused by bacteria of the genus Brucella, which is a widespread
problem in Africa [48–50] having negative public health and causing important animal
production and economic losses [51]. Hemorrhagic fevers (Ebola viral disease and Marburg
disease) constitute major public health issues in SSA where the 2870 cases (2232 Ebola
cases) documented between June 1967 and June 2011 with 1503 deaths (for Ebola) were
by far lower than the 22,859 cases and a total of 9162 deaths reported in a very short time
during the 2014–2015 outbreaks [52,53], resulting in economic growth losses ranging from
4.9 to 18.7% in affected countries [54]. Anthrax is a dreadful disease occurring in most SSA
countries [55] due to a Gram-positive, rod-shaped, and spore-forming bacterium affecting
primarily wild and domestic herbivores, resulting in high mortality rates accompanied
with an important human health [56] and bioterrorism risk when inhalation of the etiolog-
ical agent occurs in humans, causing severe respiratory symptoms associated with high
mortality rates similar to the 2001 anthrax attacks in the United States [57]. Rift Valley fever
is a vector-borne viral disease that affects mainly domestic ruminants and occasionally
humans in SSA [58,59] which is listed as one of the priority diseases in the WHO Blueprint
list because of its epidemic potential and lack of effective countermeasures. Due to the ex-
tensive livestock production systems operating in most African countries millions of people
are still at risk of contracting zoonotic tuberculosis from a range of mycobacterium species
infecting animals [60–63]. Foot and mouth disease (FMD), peste des petits ruminants (PPR),
contagious bovine pleuropneumonia (CBPP), Newcastle diseases, and contagious caprine
pleuropneumonia were the most prioritized endemic TADs causing huge production and
economic losses, although diagnostic, surveillance, and control measures exist in most
of the countries considered [64–68]. Estimates of the annual economic impact of FMD
in terms of direct production losses and vaccination in endemic regions amount to USD
6.5–21 billion [66], in addition to indirect social costs [69]. Moreover, in Niger, economic
impacts of FMD were estimated at outbreak (herd) level at 499 euros [70]. For PPR, based
on a 15-year vaccination program with total discounted costs of USD 2.26 billion, a net
benefit of USD 74.2 billion is projected [67]. Annually in 12 SSA countries, the cost of losses
due to morbidity and mortality resulting from CBPP-affected animals amounted to USD
37.8 million, while the total economic cost was estimated at USD 56.5 million or an average
of USD 4.41 million per country [64]. Contagious caprine pleuropneumonia (CCPP) is
an important respiratory disease of small ruminants that causes huge losses in Africa
and Asia with a global burden estimated at USD 507 million annually [68]. Outbreaks of
virulent Newcastle disease (ND) in poultry is often associated with high mortality (up to
100%), being therefore a major constraint on the productivity of village chicken flocks in
Africa [65,71,72].
In total, four parasitic diseases (three parasitic zoonoses and one animal disease)
were ranked between the 18 top diseases, suggesting that decision makers and experts’
perception of the impact of bacterial and viral infections is higher than the one of par-
asitic diseases. However, developed countries that have succeeded in controlling most
of the diseases prioritized in Africa are mainly focused on the introduction of emerging
and re-emerging infectious and food-borne (bacterial and viral) diseases [39–42,73]. Risk
perception of emerging and re-emerging infectious diseases varies according to stakehold-
ers [74]. Livestock keepers in Africa are rural poor pastoralists, and with regard to priority
diseases, it has been found that the perception of the poor themselves varied widely from
expert opinion and para-veterinarians and community animal health workers that share
the day-to-day life of farmers [75]. Thus, at the local level despite not being diseases
properly speaking, ectoparasite infestations were top ranked, followed by known diseases
or syndromes such as contagious bovine pleuropneumonia (CBPP), foot and mouth disease
(FMD), blackleg, bloody diarrhea, and pasteurellosis [35]. Similarly, at national/regional
levels, the top constraints that emerged from a prioritization process including three ap-
proaches (literature review, expert workshops, and para-veterinarian practitioner surveys)
were endo/ectoparasites, FMD, brucellosis, peste des petits ruminants, Newcastle disease,
avian influenza, contagious caprine pleuropneumonia, contagious bovine pleuropneu-
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monia, mastitis, reproductive disorders, and nutrition constraints [36]. The listing of
endo/ectoparasite infestations and nutrition constraints as major animal health problems
in farming communities shows that more research is required to better understand and
bridge the differences between decision makers and the farmers about their perception
of disease impacts [75] for efficient animal and zoonotic disease prevention and control
at all levels. In this regard, community animal health workers and local public health
professionals could play a great role. Thus, as far as stakeholders are concerned, in addition
to area of expertise and multisectoral considerations, prioritization processes should go
down to the field or community health practitioners and representative of farmers. Such an
approach should make sure to minimize stakeholder-driven prioritization biases, and fund-
ing/research priorities should align with improving the welfare of smallholder livestock
keepers while taking into consideration human and environmental health interests [36,76]
by therefore mitigating subjectivity (individual or group), enhancing transparency needed
for disease prioritization exercises, and combining both natural and social sciences re-
search during prioritization processes [5]. Yet disease prioritization processes should be
updated as new information affecting drivers or criteria measurements arises [2]. Only
then through cooperation and coordination can the effectiveness of disease research and
control programs (pooling of resources, knowledge and means of control, comprehensive
understanding of the impact of diseases, etc.) can be improved.
At the time of this study, five countries (Ghana, Rwanda, Senegal, Sierra Leone, and
South Africa) that prioritized zoonotic diseases using the OHZDP tool had not published
their reports yet, and all Phylum country prioritization processes were considered. Thus,
the prioritization processes reviewed in this study and carried out at the regional and
national level are in no way exhaustive though representative and may be only partly
useful at the local level where a full list of disease constraints should be identified based on
production systems. In this regard, prioritization processes should be implemented in a
standardized format that can be flexibly used whatever the scale and stakeholders involved
such as multicriteria decision analysis (MCDA), which is a set of methods from decision
science that have been recently used for disease prioritization [41,77]. However, these
prioritization processes were important steps toward building and harmonizing technical
laboratory and surveillance networks to coordinate projects addressing priority zoonoses
and TADs at the country and/or sub-regional level while improving sub-regional and
regional legislative frameworks for prevention and control initiatives at the human, animal,
and environment interface. Those processes are already being supported by international
organization such as the FAO, OIE, and WHO [78] and should be enhanced.
4. Materials and Methods
We attempted to gather details of all published (journal articles, reports published
in English and French languages) studies and reports involving animal and zoonotic
disease prioritization in sub-Sahara Africa (SSA) (Figure 3). Country-specific reports of
animal and zoonotic disease prioritization carried out using the One Health Zoonotic
Disease Prioritization Process (OHZDP) designed by the CDC [10], the Phylum tool of
OIE [3], surveys, and participatory epidemiology were also retrieved online for data
extraction. African countries that had not published their prioritization reports before
February 2021 were not included in the present study. We excluded all publications/reports
not concerning animal and zoonotic diseases prioritization in SSA. We searched through
3 databases: PubMed, Google Scholar, and AJOL (African Journals OnLine). As search
terms, we used animal and/or zoonotic and disease and prioritization in Africa, because
our interest is animal disease prioritization no matter the time, scale, and species but
limited to SSA countries. A set of data extracted from each paper/report concerned
participant institutions, selected prioritization criteria, criteria weight, diseases selected for
prioritization, and disease normalized scores. Participants’ profiles with respect to their
institutions/sector of activity were descriptively analyzed. Criteria identified and used
for prioritization were aggregated, and their mean weights were compared to analyze
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their influence on the classification. Data were aggregated according to the prioritization
method used and analyzed using Microsoft Excel (Microsoft, Redmond, WA, USA).




Figure 3. Systematic search of papers and reports on zoonosis and transboundary animal disease (TADs) prioritization 
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pating stakeholders. Then, diseases that have the greatest impact on livestock production 
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eral agreement of priority zoonoses whatever the tool used for prioritization except for 
some diseases or syndromes seen as important for farmers or practitioners. The limitations 
of each prioritization process were discussed and ways of improvement were presented. 
Few research studies have focused on synthetizing disease prioritization outcomes from 
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Figure 3. Systematic search of papers and reports on zoonosis and transboundary animal disease (TADs) prioritization
processes in Africa before February 2021. * OHZDP: One Health Zoonotic Disease Prioritization.
5. Conclusions
Animal husbandry in SSA is strongly constrained by diseases that have various
economic and public health impacts. In this critical review, we have analyzed several
zoonosis and animal disease prioritization processes carried out in SSA. By aggregating
data for tools that were used several times for prioritization, we characterized criteria
and participating stakeholders. Then, diseases that have the greatest impact on livestock
production and public health according to stakeholders were identified and ranked. There
was a general agreement of priority zoonoses whatever the tool used for prioritization
except for some diseases or syndromes seen as important for farmers or practitioners.
The limitations of each prioritization process were discussed and ways of improvement
were presented. Few research studies have focused on synthetizing disease prioritization
outcomes from diverse prioritization methods and questioning the operationalization of the
surveillance and control of the prioritized diseases. Thus, in SSA, the operationalization of
outcomes from the prioritization of zoonoses and TADs at the regional, country, local, and
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farm levels can be certainly improved by involving all stakeholders particularly at the local
level through standardized prioritization methods such as multicriteria decision analysis.
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